Progestins: pro-senescence therapy for ovarian cancer?
- PMID: 23708445
- PMCID: PMC3713123
- DOI: 10.4161/cc.25072
Progestins: pro-senescence therapy for ovarian cancer?
Keywords: FOXO1; immune therapy; ovarian cancer; progesterone; senescence.
Figures
Comment on
-
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.Cell Cycle. 2013 May 1;12(9):1433-49. doi: 10.4161/cc.24550. Epub 2013 Apr 10. Cell Cycle. 2013. PMID: 23574718 Free PMC article.
References
-
- Langdon SP, Gabra H, Bartlett JM, Rabiaz GJ, Hawkins RA, Tesdale AL, et al. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. Clin Cancer Res. 1998;4:2245–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous